1. Disease progression-associated alterations in fecal metabolites in SAMP1/YitFc mice, a Crohn's disease model.
- Author
-
Komatsu, Yosuke, Shimizu, Yu, Yamano, Megumi, Kikuchi, Mani, Nakamura, Kiminori, Ayabe, Tokiyoshi, and Aizawa, Tomoyasu
- Subjects
CROHN'S disease ,INFLAMMATORY bowel diseases ,MICROBIAL metabolites ,MEDICAL model ,METABOLITES ,SHORT-chain fatty acids ,GASTROINTESTINAL diseases - Abstract
Introduction: Crohn's disease (CD) is a chronic, relapsing inflammatory bowel disease affecting the gastrointestinal tract. Although its precise etiology has not been fully elucidated, an imbalance of the intestinal microbiota has been known to play a role in CD. Fecal metabolites derived from microbiota may be related to the onset and progression of CD Objectives: This study aimed to clarify the transition of gut microbiota and fecal metabolites associated with disease progression using SAMP1/YitFc mice, a model of spontaneous CD Methods: The ileum tissues isolated from SAMP1/YitFc mice at different ages were stained with hematoxylin–eosin for histologic characterization with CD progression. Feces from control, Institute of Cancer Research (ICR; n = 6), and SAMP1/YitFc (n = 8) mice at different ages were subjected to microbial analysis and
1 H nuclear magnetic resonance (NMR) analysis to investigate fluctuations in gut microbiota and fecal metabolites with CD progression Results: Relative abundance of the Lachnospiraceae, Ruminococcaceae, Bacteroidaceae, and Bacteroidales S24-7 at family-level gut microbiota and fecal metabolites, such as short-chain fatty acids, lactate, glucose, xylose, and choline, dramatically fluctuated with histologic progression of intestinal inflammation in SAMP1/YitFc mice. Unlike the other metabolites, fecal taurine concentration in SAMP1/YitFc mice was higher than ICR mice regardless of age Conclusion: The fecal metabolites showing characteristic fluctuations may help to understand the inflammatory mechanism associated with CD, and might be utilized as potential biomarkers in predicting CD pathology. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF